Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer
International Journal of Molecular Sciences · 14.07.2023 · 24 (14) · 11433
DOI: 10.3390/ijms241411433 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2023. Verfasst von Mehdi Felfli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Median Technologies, F-06560 Valbonne, France. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Assessment of the quality and current performance of computed tomography (CT) radiomics-based models in predicting epidermal growth factor receptor (EGFR) mutation status in patients with non-small-cell lung carcinoma (NSCLC). Two medical literature databases were systematically searched, and articles presenting original studies on CT radiomics-based models for predicting EGFR mutation status were retrieved. Forest plots and related statistical tests were performed to summarize the model performance and inter-study heterogeneity. The methodological quality of the selected studies was assessed via the Radiomics Quality Score (RQS). The performance of the models was evaluated using the area under the curve (ROC AUC). The range of the Risk RQS across the selected articles varied from 11 to 24, indicating a notable heterogeneity in the quality and methodology of the included studies. The average score was 15.25, which accounted for 42.34% of the maximum possible score. The pooled Area Under the Curve (AUC) value was 0.801, indicating the accuracy of CT radiomics-based models in predicting the EGFR mutation status. CT radiomics-based models show promising results as non-invasive alternatives for predicting EGFR mutation status in NSCLC patients. However, the quality of the studies using CT radiomics-based models varies widely, and further harmonization and prospective validation are needed before the generalization of these models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Median Technologies, F-06560 Valbonne, France.
- Centre Antoine Lacassagne, F-06100 Nice, France.
- AP-HP, Service d'Imagerie Adulte, Hôpital Necker Enfants Malades, Université de Paris Cité, F-75015 Paris, France.
- CNRS UMR 7371, INSERM U 1146, Laboratoire d'Imagerie Biomédicale, Sorbonne Université, F-75006 Paris, France.
ORCID-Profile: Mehdi Felfli, Yan Liu, Sylvain Bodard
Zitieren
APA
Felfli, M., Liu, Y., Zerka, F., Voyton, C., Thinnes, A., Jacques, S., Iannessi, A., & Bodard, S. (2023). Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences, 24(14), 11433. https://doi.org/10.3390/ijms241411433
Vancouver
Felfli M, Liu Y, Zerka F, Voyton C, Thinnes A, Jacques S, et al. Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences. 2023;24(14):11433. doi:10.3390/ijms241411433
BibTeX
@article{Felfli2023,
author = {Felfli, Mehdi and Liu, Yan and Zerka, Fadila and Voyton, Charles and Thinnes, Alexandre and Jacques, Sebastien and Iannessi, Antoine and Bodard, Sylvain},
title = {Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {14},
pages = {11433},
doi = {10.3390/ijms241411433}
}
EUVIMED